Ke, Yuhe
Jin, Liyuan
Ong, Jasmine Chiat Ling https://orcid.org/0000-0001-6916-5960
Thirunavukarasu, Arun J. https://orcid.org/0000-0001-8968-4768
Car, Josip https://orcid.org/0000-0001-8969-371X
Cheung, Carol Y. https://orcid.org/0000-0002-9672-1819
Tham, Yih Chung https://orcid.org/0000-0002-6752-797X
Ting, Daniel Shu Wei https://orcid.org/0000-0003-2264-7174
Ong, Marcus Eng Hock
Compton, Scott
Narayan, Aditee
Keane, Pearse A. https://orcid.org/0000-0002-9239-745X
Wong, Tien Yin https://orcid.org/0000-0002-8448-1264
Bates, David W. https://orcid.org/0000-0001-6268-1540
Tan, Patrick https://orcid.org/0000-0002-0179-8048
Funding for this research was provided by:
Duke-NUS Medical School
Article History
Received: 30 January 2026
Accepted: 30 April 2026
First Online: 22 May 2026
Competing interests
: P.A.K. is a cofounder of Cascader Ltd. and has acted as a consultant for Skleo Health, insitro, Retina Consultants of America, Roche, Boehringer-Ingelheim and Bitfount and is an equity owner in Big Picture Medical. P.A.K. has received speaker fees from Zeiss, Thea, Apellis and Roche, grant funding from Roche and travel support from Bayer and Roche, and has attended advisory boards for Topcon, Bayer, Boehringer-Ingelheim and Roche. C.Y.C. is a cofounder of i-Cognition Sciences Ltd. and InnoEye Focus Ltd. All other authors declare no competing interests.